FODIAC

Project Title
Foods for diabetes and cognition
Project Type
Nacional / Public
Funding Body
Funding Program
H2020 MSCA-RISE-2017 - Marie Skłodowska-Curie Research and Innovation Staff Exchange
Reference
778388
Funding
  • CEB: 45 000,00
  • Total: 432 000,00
Start
01-04-2018
End
31-03-2022
Partnership
INL, UMinho (PT), ULund (SE), Univ. of Reading (UK), SONAE (PT), ANFACO-CEC (ES), A&R House BCL (UK), Universita Cattolica Del Sacro Cuore (IT), DECORGERL SA (PT), CSIC (ES), Bioinicia SL (ES), EVRA S.R.L (IT), GERIATROS SA (ES), Casa EMMA (IT), UCP (PT)
External link
Internal link

Principal Investigator

Abstract

FODIAC aims to develop a dietary solution to tackle type 2 diabetes and cognitive dysfunction of the elderly. FODIAC will enhance the quality of R&I in Europe, promoting cooperation along the Food Value Chain. This is achieved through advanced international, intersectoral, cooperation between 7 academic and 8 industry partners. For this purpose, FODIAC assembles a European multi/interdisciplinary consortium, composed of partners in 5 countries that provide expertise in: extraction and purification of bioactive molecules, nanotechnology, nano/micro-encapsulation, toxicology, nutrition, biomarkers, clinical trial management. Rationale: lack of knowledge sharing among academia and industry acts as a barrier for the development of functional foods for the elderly, who represent one of the fastest-growing population segments worldwide. Approach and Outcomes: FODIAC coordinates the actions of individual partners, academic and industrial, using Exchange of Staff as a tool to capitalize on complementary competences to: i) conduct joint research; ii) protect the Intellectual Property based on this research; iii) foster the transference of the generated knowledge, skills, and technology to the industrial sector; and iv) exploit research output to the benefit of society. FODIAC’s outcomes will include: i) an increase in the R&I capacity among participating partners; ii) boosting of knowledge transfer of emerging micro/nano-biotechnologies from academia to industry, to develop cost-effective processes; iii) commercialization of new functional ingredients and functional foods containing antidiabetic and cognitive-enhancing bioactive molecules; iv) acceleration of the development of dietary recommendations and interventions based on those products, to improve the quality of life of the elderly; iv) a sustainable research network of academic and industrial partners and v) the leveraging of career perspectives of individual researchers, both in and outside academic institution